CG Oncology CGON Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $32.49M-87.4% | $257.07M+3,010% | $8.27M— | ||
| $709.67M+46.3% | $484.93M+170% | $179.41M— | ||
| $688K-11.9% | $781K+749% | $92K— | ||
| $1.57M— | $0— | —— | ||
| $759.48M+0.7% | $754.21M+289% | $194.12M— | ||
| $15.6M+5,634% | $272K+294% | $69K— | ||
| $10.3M— | $0— | —— | ||
| $575K— | $0— | —— | ||
| $791.59M+4.9% | $754.8M+279% | $199.3M— | ||
| $28.76M+45.7% | $19.74M+410% | $3.87M— | ||
| $30.84M+44.3% | $21.37M+49.9% | $14.25M— | ||
| $3M— | $0— | —— | ||
| $38.99M+82.0% | $21.42M+47.6% | $14.51M— | ||
| $8K0.0% | $8K— | —— | ||
| -$378.98M-73.9% | -$217.98M-67.8% | -$129.94M— | ||
| $752.6M+2.6% | $733.38M+696% | -$123.1M-58.4% | ||
| $791.59M+4.9% | $754.8M+279% | $199.3M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can CG Oncology cover its short-term obligations?
- Its current ratio is 31.30 — current assets exceed current liabilities.
- Where does CG Oncology's balance sheet data come from?
- Every line is extracted from CG Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.